Promedica Brexidol - for muscle and joint pain - 8 medicated plasters 14mg (damaged package)

Product Description

Anti-inflammatory and pain-relieving medicated plasters

Therapeutic indications
Brexidol Cerotti are used in the treatment of painful and inflammatory conditions of a rheumatic and traumatic nature of the joints, muscles, tendons and ligaments.

Dosage and method of use
Brexidol Cerotti is administered according to the following methods: it is recommended to use only one medicated plaster at a time and replace it every 24 hours for a period not exceeding 8 days. Do not apply two plasters in the same day. The product is to be used exclusively on intact skin.

After carefully washing and drying the painful area, rub one of the corners between your fingers to remove the protective film and apply the adhesive side directly to the skin. If the patch needs to be applied to joints with greater mobility, such as the elbow or knee, it is advisable to use a retention bandage to be applied to the flexed joint, in order to keep the patch in place.

Contraindications

• Hypersensitivity to the active substance (piroxicam) or to any of the excipients.
• Patients in whom substances with a similar mechanism of action (NSAIDs) have caused hypersensitivity reactions.
• Patients with active peptic ulcer, patients with bronchial asthma, history of gastrointestinal bleeding from NSAIDs.
• Patients on anticoagulant therapy.
• Pregnancy and breastfeeding.
• Children under 12 years of age.
• The patch should not be used in children under 12 years of age. be used on open wounds or lesions, but only on intact skin.
• Avoid contact with eyes and mucous membranes.

Special warnings
Serum levels achieved with the medicine were significantly lower than those obtained through oral administration, but with strong individual variability, so the onset of systemic side effects, especially at the gastrointestinal level, cannot be ruled out. Analgesics, antipyretics, and nonsteroidal anti-inflammatory drugs, including piroxicam, can cause hypersensitivity reactions, potentially serious even in subjects not previously exposed to this type of drug. These include asthma attacks, skin rashes, allergic rhinitis, and anaphylactic-type reactions.

Use with caution in patients with chronic obstructive bronchial disease, allergic rhinitis, or inflammation of the nasal mucosa (nasal polyps), in whom asthma attacks or localized inflammatory reactions of the skin and mucosa (Quincke's edema) are more frequent. Use caution in patients with a history of peptic ulcer, in patients with a history of gastrointestinal bleeding not secondary to the administration of NSAIDs or with other bleeding disorders, in patients with Crohn's disease or ulcerative colitis, with severe liver or kidney dysfunction, or with heart failure.

Prolonged or repeated use of products for skin use may give rise to sensitization phenomena. If hypersensitivity reactions occur, therapy should be discontinued. Caution should be exercised when treating elderly patients, who are generally more prone to adverse events. To avoid possible hypersensitivity or photosensitivity reactions, avoid exposure to direct sunlight.

Pregnancy and breastfeeding
It is contraindicated during pregnancy and breastfeeding and is not recommended in women intending to become pregnant. Administration should be suspended in women with fertility problems or who are undergoing fertility investigations.

Expiry and storage
Check the expiry date indicated on the package. The expiry date indicated on the package refers to the product in its intact packaging, stored correctly.

Warning: Do not use the medicine after the expiry date indicated on the package.

Composition
Brexidol Patches contain:
Active ingredient: 14 mg piroxicam
Excipients: Acrylic copolymer, Eudragit E 100; non-woven fabric, siliconized polyester.